Feng Qin Selected Research

Heterophile Antigens

6/2018	Effect of membrane-bound complement regulatory proteins on tumor cell sensitivity to complement-dependent cytolysis triggered by heterologous expression of the α-gal xenoantigen.
6/2014	CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of α-gal xenoantigen in colon tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Feng Qin Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 03/2010
10	Dehydration (Water Stress) 01/2019 - 07/2004
9	Erectile Dysfunction 06/2022 - 04/2013
8	Pain (Aches) 11/2021 - 05/2003
8	Fibrosis (Cirrhosis) 03/2021 - 06/2009
5	Hypoxia (Hypoxemia) 10/2021 - 09/2019
5	Inflammation (Inflammations) 09/2021 - 09/2009
5	Myocardial Infarction 04/2018 - 12/2008
4	Adenocarcinoma of Lung 01/2022 - 03/2010
4	Asthma (Bronchial Asthma) 10/2019 - 03/2013
4	Ischemia 07/2018 - 05/2009
4	Infarction (Infarctions) 01/2011 - 12/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2003
3	Carcinogenesis 10/2018 - 03/2010
3	Atherosclerosis 07/2018 - 02/2003
3	Dyspepsia (Indigestion) 09/2011 - 01/2009
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Constipation 05/2021 - 01/2018
2	Breast Neoplasms (Breast Cancer) 04/2021 - 05/2008
2	Lung Neoplasms (Lung Cancer) 02/2021 - 07/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 12/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2019
2	Reperfusion Injury 07/2018 - 10/2015
2	Osteoporosis 01/2018 - 08/2016
2	Priapism 01/2018 - 12/2013
2	Myocardial Ischemia (Ischemic Heart Diseases) 02/2010 - 05/2009
1	Cognitive Dysfunction 05/2022
1	Memory Disorders (Memory Loss) 05/2022
1	Osteoarthritis 03/2022
1	Bronchitis 02/2022
1	Acidosis 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Postoperative Pain 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Brain Diseases (Brain Disorder) 01/2022

Drug/Important Bio-Agent (IBA)

8	ElementsIBA 01/2019 - 07/2004
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2008
7	Transcription Factors (Transcription Factor)IBA 10/2017 - 07/2004
6	Therapeutic UsesIBA 02/2022 - 03/2013
5	Biomarkers (Surrogate Marker)IBA 02/2022 - 08/2016
5	Complement System Proteins (Complement)IBA 01/2020 - 03/2010
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
4	Ion Channels (Ion Channel)IBA 11/2021 - 07/2003
4	Caspase 3 (Caspase-3)IBA 01/2011 - 12/2008
3	Oxygen (Dioxygen)IBA 10/2021 - 01/2018
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2021 - 09/2019
3	CollagenIBA 03/2021 - 06/2009
3	trantinterolIBA 10/2018 - 03/2013
3	AntigensIBA 06/2018 - 03/2010
3	TRPV Cation ChannelsIBA 01/2011 - 11/2004
3	Capsaicin (Zostrix)FDA Link 09/2009 - 07/2003
2	Sevoflurane (Ultane)FDA LinkGeneric 05/2022 - 01/2022
2	Amino Acids FDA Link 02/2022 - 09/2021
2	AcidsIBA 01/2022 - 05/2003
2	HomocysteineIBA 01/2022 - 01/2019
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2022 - 07/2018
2	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2018
2	SaltsIBA 01/2022 - 04/2007
2	Biological ProductsIBA 01/2022 - 03/2010
2	AndrogensIBA 05/2021 - 12/2013
2	TeaIBA 01/2021 - 05/2006
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2018
2	LipidsIBA 01/2021 - 01/2019
2	Peptides (Polypeptides)IBA 01/2021 - 01/2018
2	SuspensionsIBA 10/2019 - 10/2006
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 10/2017
2	Heterophile AntigensIBA 06/2018 - 06/2014
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 04/2018 - 01/2018
2	peoniflorinIBA 01/2018 - 01/2011
2	Prednisolone (Predate)FDA LinkGeneric 01/2018 - 08/2016
2	gushudanIBA 01/2018 - 08/2016
2	chaihu-shugan-sanIBA 03/2013 - 09/2011
2	ferulic acid (sodium ferulate)IBA 09/2011 - 01/2011
2	xiaoyaoIBA 11/2010 - 08/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010 - 06/2009
2	guan xin IIIBA 01/2010 - 05/2009
2	Interleukin-6 (Interleukin 6)IBA 01/2010 - 06/2009
1	Heavy MetalsIBA 06/2022
1	Glycerophospholipids (Phosphoglycerides)IBA 05/2022
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 02/2022
1	AlkaloidsIBA 02/2022
1	lysophosphatidylethanolamineIBA 02/2022
1	General AnestheticsIBA 01/2022
1	Propofol (Diprivan)FDA LinkGeneric 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	2,4-Dichlorophenoxyacetic Acid (2,4 Dichlorophenoxyacetic Acid)IBA 01/2022
1	CholesterolIBA 01/2022

Therapy/Procedure

18	Therapeutics 03/2022 - 12/2005
5	Prostatectomy (Retropubic Prostatectomy) 03/2021 - 04/2013
4	Radiotherapy 01/2022 - 01/2016
4	Drug Therapy (Chemotherapy) 02/2021 - 03/2013
4	Oral Administration 01/2018 - 01/2009
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2021 - 09/2011
3	Aftercare (After-Treatment) 05/2021 - 05/2008
2	Anesthesia 01/2022 - 01/2022
2	Nerve Crush 05/2021 - 03/2021
2	Root Canal Therapy 01/2021 - 12/2005
2	Photochemotherapy (Photodynamic Therapy) 01/2021 - 06/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2022